New approaches to treat Alzheimer Disease

dc.contributor.author	Tejedor Estrada, Elisenda
dc.date.accessioned	2019-12-18T14:37:00Z
dc.date.available	2019-12-18T14:37:00Z
dc.date.issued	2019-11
dc.description	Premis Pharmanews-Fedefarma 2019	ca
dc.description.abstract	A few months ago, a promising study about Alzheimer Disease (AD), a type of dementia, was published in JACC (Journal of the American College of Cardiology). Dementia affects around 50 million people worldwide and around 60-70% of them suffer AD. It is estimated that in 2050 there will be more than 115 million people diagnosed (WHO, 2019). Dementia is a disease that damages cognitive capacity interfering in daily activities. AD is a progressive dementia that worsens through time and lasts around 10-12 years, when the patient dies due to infections or other organic failure...	ca
dc.format.extent	4 p.
dc.format.mimetype	application/pdf
dc.identifier.uri	https://hdl.handle.net/2445/146943
dc.language.iso	eng	ca
dc.rights	cc-by-nc-nd (c) Tejedor Estrada, 2019
dc.rights.accessRights	info:eu-repo/semantics/openAccess	ca
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/es/	*
dc.source	Premis Fedefarma: Concòrdia / Pharmanews (Facultat de Farmàcia i Ciències de l'Alimentació)
dc.subject.classification	Malaltia d'Alzheimer	cat
dc.subject.classification	Malalties neurodegeneratives	cat
dc.subject.other	Alzheimer's disease	eng
dc.subject.other	Neurodegenerative Diseases	eng
dc.title	New approaches to treat Alzheimer Disease	ca
dc.type	info:eu-repo/semantics/bachelorThesis	ca

Fitxers

Mostrant 1 - 1 de 1

Nom:: 3-Elisenda Tejedor Estrada-New approaches to treat Alzheimer Disease.pdf
Mida:: 117.53 KB
Format:: Adobe Portable Document Format
Descripció: